VolitionRx (VNRX) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free VNRX Stock Alerts $0.89 +0.01 (+1.14%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVolitionRx (NYSEAMERICAN:VNRX) Stock Price Crosses Above 50-Day Moving Average of $0.00americanbankingnews.com - May 3 at 4:38 AMNu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antechfinance.yahoo.com - April 23 at 8:32 AMVolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 28 at 9:28 PMVolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 27 at 1:35 PMTELA Bio launches Liquifix surgical devices in the U.S.msn.com - March 21 at 8:51 AMVolition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japanfinance.yahoo.com - March 20 at 3:56 PMVolition to Share Nu.Q® NETs Strategy Update at Upcoming Webinarfinance.yahoo.com - February 2 at 8:24 AMVolitionRx has 'compelling plans' to advance veterinary care in 2024proactiveinvestors.com - January 6 at 1:49 PMVolition Issues Business Review 2023finance.yahoo.com - January 4 at 10:08 AMAnalysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Universal Health (UHS) and VolitionRX (VNRX)markets.businessinsider.com - January 3 at 11:43 PMVolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - November 14 at 4:36 PMVNRX: Breakthrough Cancer Detection Method Disclosed at ESMO and in a Webinar - preliminary proof of concept work indicates simple blood test should be able to detect several types of cancer, potentially at Stages I & IIfinance.yahoo.com - November 2 at 12:57 PMVolitionRX (VNRX) Price Target Increased by 7.93% to 3.76msn.com - November 1 at 8:26 AMEF Hutton Initiates Coverage of VolitionRX (VNRX) with Buy Recommendationmsn.com - October 31 at 8:04 AMCantor Fitzgerald Reaffirms Their Buy Rating on VolitionRX (VNRX)markets.businessinsider.com - October 28 at 7:42 AMVolitionRx hails study showing Nu.Q NETs promise as biomarker for septic shockproactiveinvestors.com - October 19 at 10:40 AMMeasuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shockfinance.yahoo.com - October 19 at 8:38 AMVolitionRx welcomes US Ambassador to Belgium for exclusive tour of research facilitiesproactiveinvestors.com - October 18 at 1:09 PMUS Ambassador Adler visits Belgian Volitionfinance.yahoo.com - October 18 at 1:09 PMVolitionRx to present cancer detection abstracts at European oncology conferenceproactiveinvestors.com - October 16 at 10:31 AMVolition Presents Three Cancer Detection Abstracts at ESMO 2023finance.yahoo.com - October 16 at 8:51 AMVolitionRx holds roundtable on sepsis managementproactiveinvestors.com - October 13 at 9:45 AMVolition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsisfinance.yahoo.com - October 13 at 9:45 AMVolitionRx to unveil new cancer detection method insights at upcoming webinarproactiveinvestors.com - October 4 at 6:39 PMVolition to Reveal New Cancer Detection Method Insights at Upcoming Webinarfinance.yahoo.com - October 2 at 9:35 AMVolitionRx, Avalo Therapeutic among healthcare moversmsn.com - September 22 at 3:47 PMVolition Hosts Key Opinion Leader Roundtable on Sepsis Managementfinance.yahoo.com - September 13 at 8:34 AMVolitionRx (VNRX): Review of 2Q 2023; Distribution Footprint of Nu.Q Vet Cancer Test is expanding. Prolific Schedule of Clinical Papers & Posters.finance.yahoo.com - August 25 at 1:46 PMMaxim Group Reaffirms Their Buy Rating on VolitionRX (VNRX)markets.businessinsider.com - August 23 at 2:37 PMVolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - August 14 at 4:24 PMHere's what Wall Street expects from VolitionRX's earningsmarkets.businessinsider.com - August 13 at 11:05 AMVolitionRx: Equity raise reaches US$19.5mln as underwriter...VolitionRx: Equity raise reaches US$19.5mln as underwriter...proactiveinvestors.com - June 26 at 8:34 AMVolitionRx Limited prices major public offering to fund research and product developmentproactiveinvestors.com - June 1 at 3:45 PMVolitionRx proposes public offeringmsn.com - June 1 at 10:12 AM8-K: VOLITIONRX LTDmarketwatch.com - May 12 at 12:32 AMVolitionRx reports cash and cash equivalents of $10M at 1Q-endproactiveinvestors.com - May 11 at 6:25 PMVolitionRX Q1 2023 Earnings Previewmsn.com - May 10 at 6:14 PMVolitionRX's Earnings Outlookmsn.com - May 10 at 1:14 PMVolitionRx Limited to Host Capital Markets Day at the NYSE on Thursday May 11.finance.yahoo.com - April 26 at 8:05 AMMaxim Group Sticks to Their Buy Rating for VolitionRX (VNRX)markets.businessinsider.com - March 21 at 8:38 AMVolitionRX Stock (AMEX:VNRX), Guidance and Forecastbenzinga.com - March 20 at 2:01 PMVolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business Updatefinance.yahoo.com - March 10 at 9:07 AMVolitionRx Limited to Webcast Live at VirtualInvestorConferences.com March 9thfinance.yahoo.com - March 6 at 4:49 PMVNRX: Nu.Q Vet Cancer Test Being Launched by Supply Agreement Partners Heska and IDEXX; 4.945 million Share Offering Completed to Help Fund Management’s Initiativesfinance.yahoo.com - February 27 at 5:22 PMVolitionRx Limited Announces Closing of $8.7 Million Underwritten Public Offering of Common Stockfinance.yahoo.com - February 22 at 5:01 PMVolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common Stockfinance.yahoo.com - February 17 at 10:45 AMVolition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporationfinance.yahoo.com - February 16 at 8:25 AMVolition to Take Part in Nu.Q® Vet Commercial Strategy Webinarprnewswire.com - January 20 at 8:42 AMVolition Issues Business Review 2022finance.yahoo.com - January 8 at 12:58 PMVolitionRX Q3 2022 Earnings Previewseekingalpha.com - November 16 at 12:27 AM Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. VNRX Media Mentions By Week VNRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VNRX News Sentiment▼0.000.43▲Average Medical News Sentiment VNRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VNRX Articles This Week▼10▲VNRX Articles Average Week Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genetron News Eledon Pharmaceuticals News Alpha Cognition News Vaso News AVROBIO News Homology Medicines News ARCA biopharma News Gain Therapeutics News Zepp Health News IceCure Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:VNRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry4 Cryptos BETTER than BitcoinTrue Market InsidersThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
